Different Laser Frequencies on Neuropathic Outcomes in Patients With Bell's Palsy

Different Laser Frequencies on Neuropathic Outcomes in Patients With Bell's Palsy

this study was done to compare different laser frequencies on neuropathic outcomes in patients with Bell's palsy.

This study aims to compare the efficacy of different laser irradiation wavelengths (808 nm, 980 nm, and 1064 nm) in treating facial nerve lesions, which can lead to paralysis and impaired facial movement. The findings are expected to inform clinical decisions, enhance treatment outcomes, and improve rehabilitation protocols for patients with Bell's palsy, ultimately aiming to enhance their quality of life.

Inclusion Criteria:

1. Eighty subjects from both genders diagnosed with Bell's palsy will be recruited through direct referrals from their independent physician's neurology department.
2. Subjects aged 18 and above from all genders
3. Unilateral Bell's palsy either on the right or left side.
4. The Facial disability index will be used for assessment and progression of Bell's palsy before and after treatment protocol.
5. Patients will on level II, III, IV and V of House-Brackmann scale.

Exclusion Criteria:

1. We will exclude patients who had central nervous system pathology, sensory loss over the face, or recurrence of facial palsy.
2. Upper motor neuron fascial nerve palsy.
3. Any infant or child (<18 years).
4. Bilateral Facial nerve palsy
5. Severe hypertension (Blood pressure more than 200/120 mmHg).